Dr. Christopher G. J. Richards
Executive Chairman and Interim CEO
Dr. Richards joined the Company as non-executive Chairman in August 2012. He became Executive Chairman in April 2015 to take on a more active role in investor relations and in developing strategy, particularly the focus on New Technology. Dr. Richards spent 20 years at Syngenta and its predecessor companies in various strategic management positions in South America, Europe and Asia. In November 2003, he was appointed COO of Arysta LifeScience, and he served as CEO from 2004 until 2010, leading Arysta LifeScience’s transformation into a global agrochemical company with sales above $1.6 billion. He also served as a director of Arysta LifeScience from 2003 to 2015. He serves on the board of directors of Dechra plc, an international specialist veterinary pharmaceuticals business, Cibus Global Ltd., a precision gene editing company focused on non-transgenic crop breeding, and Origin Enterprises plc, a service provider to farmers for food production solutions. Dr. Richards is also the Chairman of Nanoco Group plc, a technology company carrying out research, development and commercialisation of products based on heavy-metal free quantum dots.
Michael J. Higgins
Senior Independent Director
Michael Higgins joined the Company in May 2013 as senior independent director and Chair of the Audit Committee. He also serves as a member of the Remuneration Committee. He currently serves as non-executive chairman of Ebiquity plc, an independent marketing analytics company, a non- executive director of Arria NLG plc, a software development business, a non-executive director of Progility plc, a project management services group, and chairman of the Quoted Companies Alliance, a non-profit organisation dedicated to helping small to mid-sized publicly traded companies grow. He is also a member of the Panel on Takeovers and Mergers as the appointee of the Quoted Companies Alliance. Mr. Higgins was a partner at KPMG for 10 years and subsequently served as a senior adviser at KPMG. Prior to KPMG, Mr. Higgins was a director at Charterhouse Bank, worked at Saudi International Bank and qualified as an accountant with Price Waterhouse (now PricewaterhouseCoopers).
Dr. Richard H. Webb
Dr. Webb joined the Company in September 2013 as a non-executive director. In January 2015, he was appointed an executive director, responsible for supporting the Chief Science Officer, Dr. Zhongmin Wei, as the Company continues to expand its research and development capability. He was previously engaged by the Company as a consultant, contracted through StepOut Ltd., a consultancy business he founded in 1995. In this capacity, between 2012 and 2014, he was instrumental in the development of the Company’s new business strategy and its current New Technology programme. He previously held various positions at Imperial Chemical Industries and its spinout Zeneca Agrochemicals, including responsibilities for managing laboratory discovery and field development programmes for its public health pesticide business. His doctorate, in pest biology, was from the London School of Hygiene & Tropical Medicine.
William M. Lewis
William Lewis joined the Company as a non- executive director in April 2015. Mr. Lewis is the Chair of the Remuneration Committee and a member of the Audit Committee. Since June 2014, Mr. Lewis has served as President and CEO of Summit Agro USA, LLC, a joint venture agrochemicals business between Sumitomo Corporation and ISK Biosciences. He previously held senior roles within Arysta LifeScience, Syngenta Crop Protection and Zeneca/ICI.